Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
AP file photo
The Senate HELP Committee gave a quick approval to Scott Gottlieb's nomination to head the Food and Drug Administration this morning, mostly along party lines. The only real disagreement was over Gottlieb's background as a consultant for drug companies, with Democrats charging that he'd have too many conflicts of interest. But Republicans said his consulting experience will be a positive, not a negative. Gottlieb has said he'll recuse himself as needed.
The debate in five seconds:
- "The extent of Dr. Gottlieb's entanglement with the companies he'll be overseeing is unprecedented." — Democratic Sen. Patty Murray.
- "I think we should step back and realize that we need in our government people with experience." — HELP Committee Chairman Lamar Alexander